ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
30.49
+1.17 (3.99%)
At close: Sep 30, 2026
| Market Cap | 4.62B -0.7% |
| Revenue (ttm) | 479.41M +36.4% |
| Net Income | -22.45M |
| EPS | -0.15 |
| Shares Out | 151.47M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.20 (0.66%) |
| Ex-Dividend Date | Jul 15, 2026 |
| Volume | 7,881,833 |
| Open | 29.91 |
| Previous Close | 29.32 |
| Day's Range | 29.36 - 31.18 |
| 52-Week Range | 26.90 - 65.03 |
| Beta | -0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |